A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.
暂无分享,去创建一个
A. Zelenetz | I. Flinn | T. Kipps | M. Keating | S. O'brien | J. Burger | L. Miller | S. Coutre | S. Mitra | Yeonhee Kim | N. Lamanna | A. Yu | D. Johnson | R. Dansey | R. Dubowy | Leanne Holes